These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5846409)

  • 41. The reduction of folate and of dihydrofolate by homogenates of leukocytes from patients with leukemia or with myeloid metaplasia.
    Roberts D; Hall TC
    Cancer Res; 1967 May; 27(5):994-9. PubMed ID: 6025262
    [No Abstract]   [Full Text] [Related]  

  • 42. A qualitative and quantitative assay of dihydrofolate reductase in carrot cells resistant to methotrexate.
    Nano R; Cella R; Rezzani R; Rodella L; Gerzeli G
    Basic Appl Histochem; 1989; 33(2):81-92. PubMed ID: 2757603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
    Domin BA; Grill SP; Bastow KF; Cheng YC
    Mol Pharmacol; 1982 Mar; 21(2):478-82. PubMed ID: 7099148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of effect of methotrexate on hepatic regeneration.
    Brown SS; Neal GE; Williams DC
    Nature; 1965 Jun; 206(988):1007-9. PubMed ID: 5294528
    [No Abstract]   [Full Text] [Related]  

  • 45. On the role of drug penetration in amethopterin resistance of Sarcoma-180 cells in vitro.
    Hakala MT
    Biochim Biophys Acta; 1965 May; 102(1):198-209. PubMed ID: 5890840
    [No Abstract]   [Full Text] [Related]  

  • 46. Isolation and expression of an altered mouse dihydrofolate reductase cDNA.
    Simonsen CC; Levinson AD
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2495-9. PubMed ID: 6573667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
    Allegra CJ; Boarman D
    Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on folic reductase. 3. The level of enzyme activity and response to methotrexate of transplantable mouse tumors.
    Roberts D; Wodinsky I; Hall TC
    Cancer Res; 1965 Dec; 25(11):1899-903. PubMed ID: 5856519
    [No Abstract]   [Full Text] [Related]  

  • 51. Dihydrofolate reductase from guinea pig liver and small intestine.
    Bertino JR; Iannotti AT; Perkins JP; Johns DG
    Biochem Pharmacol; 1966 May; 15(5):563-71. PubMed ID: 5227348
    [No Abstract]   [Full Text] [Related]  

  • 52. Irreversible enzyme inhibitors. 88. Differential irreversible inhibition of dihydrofolic reductase from different species.
    Baker BR; Jordaan JH
    J Pharm Sci; 1967 May; 56(5):660-1. PubMed ID: 5340324
    [No Abstract]   [Full Text] [Related]  

  • 53. [Regulation of dihydrofolic acid reductase synthesis in synchronously growing yeast cells].
    Scholz K; Jaenicke L
    Eur J Biochem; 1968 May; 4(4):448-57. PubMed ID: 4173461
    [No Abstract]   [Full Text] [Related]  

  • 54. Irreversible enzyme inhibitors. LXXI. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. V. Derivatives of 6-phenylpyrimidine.
    Baker BR; Shapiro HS
    J Pharm Sci; 1967 Jan; 56(1):33-8. PubMed ID: 6030490
    [No Abstract]   [Full Text] [Related]  

  • 55. Irreversible enzyme inhibitors. LXXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VII. Derivatives of 2,4-diaminopyrimidine. I.
    Baker BR; Jackson GD; Meyer RB
    J Pharm Sci; 1967 May; 56(5):566-70. PubMed ID: 6040577
    [No Abstract]   [Full Text] [Related]  

  • 56. Irreversible enzyme inhibitors. LXXXIV. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IX. Derivatives of 2,4-diaminopyrimidine. 3.
    Baker BR; Meyer RB
    J Pharm Sci; 1967 May; 56(5):570-6. PubMed ID: 6032766
    [No Abstract]   [Full Text] [Related]  

  • 57. Irreversible enzyme inhibitors. LXX. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IV. Substituted 1-phenyl-1,2-dihydro-s-triazines.
    Baker BR; Ho BT
    J Pharm Sci; 1967 Jan; 56(1):28-32. PubMed ID: 6030489
    [No Abstract]   [Full Text] [Related]  

  • 58. Irreversible enzyme inhibitors. LXXXVII. Hydrophobic bonding to dihydrofolic reductase. IX. Mode of binding of m-aryloxyalkyl groups on 4,6-diamino-1,2-dihdro-2,2-dimethyl-1-phenyl-s-triazine.
    Baker BR; Lourens GJ
    J Pharm Sci; 1967 Jul; 56(7):871-5. PubMed ID: 6068108
    [No Abstract]   [Full Text] [Related]  

  • 59. Irreversible enzyme inhibitors. LXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VI. Derivatives of hydrophobically bonded p-alkyl and p-aralkyl benzoic acids.
    Baker BR; Schwan TJ; Ho BT
    J Pharm Sci; 1967 Jan; 56(1):38-42. PubMed ID: 6030491
    [No Abstract]   [Full Text] [Related]  

  • 60. A rapid radioassay for folic acid reductase and amethopterin.
    Rothenberg SP
    Anal Biochem; 1966 Jul; 16(1):176-8. PubMed ID: 5966125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.